Bornea, Juhaneylyn .

HRN: 25-19-99  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/15/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/15/2026
08/22/2026
IVT
500mg
Q8
Deept SSI
Pending Pharmacy Acceptance 

 Indication:  Empirical De-escalation    Type of Infection:  Prophylaxis    Compliance to guidelines: